About REBUIMMUNITY, LLC
RebuImmunity, LLC is a pharmaceutical company focused on developing recombinant chimeric proteins for the treatment of autoimmune diseases and allograft recipients. Their lead candidate, BY-001, is in the transition phase from IND to NDA.
Development of recombinant chimeric proteinsPreclinical functional demonstration of therapeutic candidatesResearch in autoimmune disease treatments
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to REBUIMMUNITY, LLC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.